Cohen L, Morgan J, Bozyk M E
Res Commun Chem Pathol Pharmacol. 1975 Oct;12(2):363-77.
In a previous study, the efflux of creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) which takes place from isolated mouse skeletal muscle was shown to be significantly reduced by pretreatment of the intact animal with diethylstilbestrol (DES). This compound is known to reduce the high serum enzymes present in patients with Duchenne's muscular dystrophy (DMD). Glucocorticoids also reduce the serum enzymes in DMD. The purpose of this study was to determine if pretreatment with the glucocorticoid, prednisolone, also lowered the efflux from isolated mouse skeletal and cardiac muscle. The results of these studies show that prednisolone pretreatment lowers the enzyme efflux from isolated skeletal muscle, but not from heart. There is an optimal dose which produces this reduction, which if exceeded, augments the efflux. Thus two agents are now known which lower the efflux of CPK and LDH from isolated skeletal muscle. These same two agents lower the high serum enzymes in DMD. This suggests, but does not prove, that the mechanism by which these agents lower the serum enzymes in DMD is by reducing enzyme efflux from skeletal muscle.
在之前的一项研究中,已表明用己烯雌酚(DES)预处理完整动物后,从分离的小鼠骨骼肌中发生的肌酸磷酸激酶(CPK)和乳酸脱氢酶(LDH)外流量显著降低。已知该化合物可降低杜氏肌营养不良症(DMD)患者体内的高血清酶。糖皮质激素也可降低DMD患者的血清酶。本研究的目的是确定用糖皮质激素泼尼松龙预处理是否也能降低从分离的小鼠骨骼肌和心肌中的外流量。这些研究结果表明,泼尼松龙预处理可降低从分离的骨骼肌中的酶外流量,但不能降低从心脏中的酶外流量。存在一个产生这种降低效果的最佳剂量,如果超过该剂量,则会增加外流量。因此,现在已知有两种药物可降低从分离的骨骼肌中CPK和LDH的外流量。这两种相同的药物可降低DMD患者的高血清酶。这表明,但未证明,这些药物降低DMD患者血清酶的机制是通过减少骨骼肌中的酶外流量。